Latest Content

Spanning those focused on pneumococcal diseases to continued developments of vaccines against COVID-19, these are the most-read immunization stories from 2025.

Jennifer Flynn, CPHRM, vice president of health care risk management at the Healthcare Provider Service Organization, discusses pharmacists’ roles in patient privacy.

Pharmacy benefit manager reforms and new pain management options reshape the pharmaceutical landscape, enhancing patient access and care in 2025.

With brand-new challenges and opportunities in the GLP-1 space and obesity management as a whole, here are the top developments from the past year.

Marking 5 years since the COVID-19 pandemic forever changed health care in 2020, check out the top 5 COVID-19 stories from 2025.

Explore the latest advancements in pharmacy, including innovative therapies, cost-saving models, and significant reforms shaping the industry in 2025.

A recent study reveals COVID-19 vaccination significantly reduces severe maternal disease and preterm birth risks during pregnancy.

Discover critical insights on respiratory health, COVID-19 impacts, and vaccination strategies from recent studies and regional policy changes.

OTC access expands, enhancing reproductive health and migraine relief while raising safety concerns about online pharmacies and medications like Benadryl.

In part 3 of our interview with Kenric B. Ware, PharmD, MBA, AAHIVP, he discusses the best approaches for addressing HIV care and prevention stigma.

The top pneumococcal stories of 2025 explored the evolving landscape of pneumococcal vaccination.

The landmark oral formulation of the popular weight loss drug is set to launch in early 2026.

Kenric B. Ware, PharmD, MBA, AAHIVP, addresses the pharmacist’s role in addressing HIV stigma and providing public health services for patients with the virus.

The top women's health stories in 2025 included groundbreaking advancements in women's health against an alarming mortality trend.

Pharmacists play a crucial role in educating patients about birth control, improving access to care, and addressing maternal health challenges in Arkansas.

Arkansas pharmacists enhance women's health by implementing new protocols for oral contraceptive prescriptions, improving patient care and confidence.

Kenric B. Ware, PharmD, MBA, AAHIVP, presents persistently common stigmas in HIV care and prevention from a recent NPhA webinar.

Personalized insulin management and small lifestyle changes empower diabetes patients to improve their health and confidence in self-care.

The Sinovac-CoronaVac vaccine significantly reduces COVID-19 mortality in patients with schizophrenia, highlighting an increased importance of vaccination.

With little evidence on vaccine coverage for people living with HIV, researchers explored pneumococcal vaccine rates between 2014 and 2023.

Pharmacists enhance diabetes care by educating patients on insulin management, ensuring safe practices, and tailoring regimens for better glycemic control.

This December 2025 order is an extension of HHS’ recommendation to reconsider marijuana as a Schedule III medication in 2023.

Investigators analyze bureaucratic hurdles in multicountry COVID-19 trials, revealing delays that hinder timely evidence for treatment guidelines.

Health care professionals emphasize the importance of monitoring blood glucose, lifestyle changes, and patient education for effective diabetes management.

During his second term, President Trump has bolstered his approach at lowering prescription drug prices in the US through innovative yet unprecedented decisions.

Among patients previously reporting COVID-19, researchers conduct a case-control study of REM-predominant obstructive sleep apnea.

Pharmacists play a crucial role in diabetes care by educating patients on insulin management and medication adherence for better health outcomes.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with Karen Kier, PhD, RPh, BCPS, BCACP, to discuss warning labels for hormonal replacement therapy.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed potential safety concerns and the pharmacist’s role in managing insulin.

Ron Lanton III, Esq, provides nuance to the current state of pharmacy sustainability and how the MFN drug pricing policy could impact the industry.